# PAN-study: Pan-Cancer Early Detection Study (PAN)

> **NCT03756597** · — · COMPLETED · sponsor: **Owlstone Ltd** · enrollment: 268 (actual)

## Conditions studied

- Gastric Cancer
- Esophageal Cancer
- Liver Cancer

## Interventions

- **DEVICE:** ReCIVA
- **DEVICE:** CASPER

## Key facts

- **NCT ID:** NCT03756597
- **Lead sponsor:** Owlstone Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-26
- **Primary completion:** 2022-12-02
- **Final completion:** 2023-07-06
- **Target enrollment:** 268 (ACTUAL)
- **Last updated:** 2023-10-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03756597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03756597, "PAN-study: Pan-Cancer Early Detection Study (PAN)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03756597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*